IRIS
ORSI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 88
EU - Europa 67
AS - Asia 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 88
SE - Svezia 33
IT - Italia 28
CN - Cina 12
IN - India 4
IE - Irlanda 3
DE - Germania 2
EU - Europa 1
RU - Federazione Russa 1
Totale 172
Salva come PNG Salva come JPEG
Città #
Ashburn 15
Shanghai 12
Milan 11
New York 10
Lawrence 7
Princeton 7
Carlsbad 5
Seattle 4
Turin 4
Dublin 3
Hyderabad 3
Rome 3
Berlin 2
Cuneo 2
Modena 2
Reggio Emilia 2
San Maurizio Canavese 2
Brescia 1
Los Angeles 1
Pune 1
St Petersburg 1
Washington 1
Totale 99
Salva come PNG Salva come JPEG
Nome #
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 17
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 16
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 14
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 14
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 14
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 12
The impact of nutritional status on pancreatic cancer therapy 11
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 11
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 11
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 10
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 10
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 9
Pancreatic cancer: still a cold case? 9
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 9
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 9
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 9
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? 7
Lessons and open questions in borderline resectable pancreatic cancer 6
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 6
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 5
Totale 209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 5 3 0 0 1
2022/202368 14 11 5 0 1 16 3 10 2 0 6 0
2023/2024132 12 9 12 31 15 18 5 15 4 10 1 0
Totale 209